Intelligent Bio Solutions Inc.

US$1.97As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INBSHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (78.90%)
Div yield —
ROE (307.69%)
Medical Devices
Beta (5Y) 4.49
PE TTM —
TSR TTM (79.83%)
Mkt cap US$5.964M
ROIC (150.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.38
20.67%
(81.76%)
Hold 2|10|11|6|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.05
0.05
0.05
0.05
14.73%
7.00%
11.78%
9.33%
Revenue$M
0.266
0.262
0.271
0.284
0.64%
(4.72%)
(3.85%)
3.81%
Peers (US$5.964M)
Cap (US$)
PE
7.404M
—
4.676M
—
Capital
TTM
5Y
10Y
Leveragex
1.085
(0.325)
(0.268)
EBIT/Intx
1.682
3.264
3.304
Own earn%
(69.64)
72.61
68.15
Sh yield%
11.53
35.43
33.51
Owners
Insiders/Inst%
11.71
32.87
Short interest%
1.56
SBC / revenue%
3.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
10–15
$1 testx
0.0
Incr. ROIC%
2